Researchers at Cedars-Sinai developed PR-364, a drug that prevented heart failure in mice after heart attacks. The treatment ...

Although drug-eluting stents (DES ... there is still no consensus regarding the use of DES in ST-elevation myocardial infarction (STEMI). The HORIZONS-AMI trial sought to compare the safety ...

A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new ...

There is a common perception that weight cycling, often called “yo-yo dieting,” is detrimental to health. But new research ...

The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.

Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced data from the AMDS PERSEVERE clinical trial (the "IDE") was presented in a Late-Breaking ...

The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...

Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...